TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

June 12, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) shares over potential securities laws violations by Dicerna Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: